In a murine ALI model, the co-administration of luteolin (15 mg/kg) with paeoniflorin (75 mg/kg) synergistically inhibited NF-κB and MAPK signaling, leading to stronger suppression of inflammation and oxidative stress (Liu Z. et al., 2024). Here, NFKB1 is linked to acute respiratory distress syndrome.